LGALS3 and carcinoma: Considering that Tf glycoantigen (Figure 1) is exposed on up to 90% of human carcinomas (81) and is a major cancer cell surface carbohydrate ligand for Gal-3, the authors obtained synthetic peptides mimicking the Tf structure using combinatorial bacteriophage display technology.